EH
CN
Home
Haisco
Group Profile
Subsidiary Profile
Production Base
Production Equipment
Production Capacity
Products
corporate Culture
Enterprise Philosophy
Employee Benefits
Employees
Enterprise Magazine
Contact Us
Product
Narcotic Analgesics
Endocrine System Drugs
Enteral Parenteral Nutrition Drugs
Neuropsychiatric Drugs
Cardiovascular Drugs
Tumor Related Drugs
Drugs For Digestive Liver Disease
Other
Innovative R&D
Innovative R&D
Pipeline
Platform
Investor
Stock Information
Investor Hotline
Contact Us
EH
CN
Haisco
Group Profile
Subsidiary Profile
Production Base
Production Equipment
Production Capacity
Products
corporate Culture
Enterprise Philosophy
Employee Benefits
Employees
Enterprise Magazine
Contact Us
Product
Narcotic Analgesics
Endocrine System Drugs
Enteral Parenteral Nutrition Drugs
Neuropsychiatric Drugs
Cardiovascular Drugs
Tumor Related Drugs
Drugs For Digestive Liver Disease
Other
Innovative R&D
Innovative R&D
Pipeline
Platform
Investor
Stock Information
Investor Hotline
Home
>
News and media
>
media coverage
Enterprise News
media coverage
Industry dynamics
Drug administration regulations
海思科：向美国FDA递交HSK-3486乳状注射液Pre-IND会议申请
证券时报e公司讯，海思科(14.540, 0.09, 0.62%)(002653)3月18日晚公告
2019-03-18
MORE >
海思科业绩大幅增长 氟哌噻吨美利曲辛片首家通过一致性评价
2月26日，海思科(002653)发布了2018年度业绩
2019-02-26
MORE >
海思科：HSK7653片进入IIa期临床研究
e公司讯，海思科（002653）1月28日晚公告，公司全资子公司四川海思科制药于近日获得了天津市人民医院关于
2019-01-28
MORE >
1
2
3
